Responses
Other responses
Jump to comment:
- Published on: 5 March 2003
- Published on: 17 February 2003
- Published on: 5 March 2003Author's replyShow More
Dear Editor
We thank Dr Biban for his comments on our article.[1] We share his concerns that our case has some interesting and unique points. As he/she stated that our case was the first reported case of a Kasabach-Merrit syndrome (KSM) associated with a lipomatous tumor. Her severe findings due to KSM and as well as her progressively enlarging mass on the shoulder were dramatically responded to interferon therapy.[...
Conflict of Interest:
None declared. - Published on: 17 February 2003Kasabach-Merritt syndrome and interferon alpha: still a controversial issue.Show More
Dear Editor
We read with interest the paper by Akyuz and colleagues,[1] which described a 2 year old patient with a Kasabach-Merritt syndrome (KMS) secondary to an infiltrating angiolipoma, who was successfully treated with interferon alpha 2a (IFN-alpha).
Although the case presents some points of interest, such as the previously unreported association of a KMS with a lipomatous tumor and the potential effec...
Conflict of Interest:
None declared.